macular edema

(redirected from Macular oedema)
Also found in: Dictionary, Medical.
Related to Macular oedema: Macular edema
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to macular edema

an eye disease caused by a swelling of the macula resulting from leakage and accumulation of fluid

Related Words

References in periodicals archive ?
Diabetic macular oedema is diagnosed stereoscopically as retinal thickening in the macula using slit-lamp biomicroscopy.
Cystoid macular oedema and changes in retinal thickness after phacoemulsification with optical coherence tomography.
In June 2015, the company met with the US Food and Drug Administration to review the ongoing clinical activities and discussed the clinical strategy for CLS-TA using suprachoroidal space drug administration for the treatment of macular oedema associated with non-infectious uveitis.
These messenger proteins cause inflammation which plays a role in CRVO-related macular oedema.
UK regulator will draft the ultimate guidance and has endorsed the therapy for macular oedema caused by central or branch retinal vein occlusion - common conditions that can affect a patient's ability to see detail and colour.
Macular oedema occurs when fluid leaks from the small blood vessels in the eye and distorts vision.
Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.
Objective: To evaluate the results of posterior sub-tenon triamcinolone acetonide in patients of refractory macular oedema suffering with retinal vascular disorders.
Macular oedema is a common complication of diabetic retinopathy, retinal venous occlusions, intraocular surgery, and variety of retinal diseases.
Surgical treatment of chronic macular oedema with a combination therapy.
The product is to be used for the treatment of visual impairment due to diabetic macular oedema.
DRAFT GUIDANCE released by NICE has recommended the acetonide intravitreal implant, Iluvien, for the treatment of chronic diabetic macular oedema in pseudophakic patients who are found to respond insignificantly to alternative treatments which are available.